Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells
Nicola Tumino, Piera Filomena Fiore, Andrea Pelosi, et al.
Seminars in Immunology (2022) Vol. 61-64, pp. 101668-101668
Open Access | Times Cited: 21

Showing 21 citing articles:

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 60
Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs
Shengwen Shao, Huilai Miao, Wenxue Ma
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Monocytes in Tumorigenesis and Tumor Immunotherapy
Xiaodie Chen, Yunqing Li, Houjun Xia, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1673-1673
Open Access | Times Cited: 26
Bridging Chronic Inflammation and Digestive Cancer: The Critical Role of Innate Lymphoid Cells in Tumor Microenvironments
Guanliang Shen, Qi Wang, Zhengrui Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 12, pp. 4799-4818
Open Access | Times Cited: 14
Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target
Marsha Pellegrino, Valerio Secli, Silvia D’Amico, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Probiotics and gut microbiota modulation: implications for skin health and disease management
Elahe Parhizkar, Parisa Vosough, Maryam Baneshi, et al.
Archives of Microbiology (2025) Vol. 207, Iss. 3
Closed Access | Times Cited: 1
Tumor microenvironment diversity and plasticity in cancer multidrug resistance
Zhi Li, Peihao Yin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188997-188997
Closed Access | Times Cited: 16
NLRP6 deficiency suppresses colorectal cancer liver metastasis growth by modulating M-MDSC-induced immunosuppressive microenvironment
Liangzheng Chang, Lei Xu, Yuying Tian, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167035-167035
Open Access | Times Cited: 5
Myeloid-derived suppressor cells exhibit distinct characteristics in bone marrow and blood of individuals with diffuse large B-cell lymphoma
Paris Efstratiou, Athina Damianaki, Aglaia Kavidopoulou, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Cytokine-mediated regulation of immune cell metabolic pathways in the tumor microenvironment
Alireza Soleimani Mamalo, Mohammad Reza Pashaei, Mohammad Valilo, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Crosstalk between colorectal cancer cells and cancer-associated fibroblasts in the tumor microenvironment mediated by exosomal noncoding RNAs
Shichen Sun, Yanyu Zhang, Yubing Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Targeting intracellular proteins with cell type-specific functions for cancer immunotherapy
Madison E. Carelock, Rohan P. Master, Myung‐Chul Kim, et al.
Life Medicine (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 5
Targeting myeloid-derived suppressor cells in the tumor microenvironment: potential therapeutic approaches for osteosarcoma
Hye In Ka, Se Hwan Mun, Sora Han, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 33, Iss. 3, pp. 519-531
Closed Access | Times Cited: 1
Review: Comparison of traditional and modern diagnostic methods in breast cancer
Hussein Kareem Elaibi, Farah Fakhir Mutlag, Ebru Halvacı, et al.
Measurement (2024), pp. 116258-116258
Closed Access | Times Cited: 1
Immunomodulatory actions of myeloid-derived suppressor cells in the context of innate immunity
Nikoleta Bizymi, Andreas Μ. Matthaiou, Irene Mavroudi, et al.
Innate Immunity (2023) Vol. 30, Iss. 1, pp. 2-10
Open Access | Times Cited: 3
Interleukin-10 overexpression in 4T1 cells: A gateway to suppressing mammary carcinoma growth
Xiaoqin Wang, Xiaoqian Wang, Dan Wang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113089-113089
Open Access
Myeloid-derived suppressor cells: Identification and function
Paola Vacca, Maria Teresa Bilotta, Lorenzo Moretta, et al.
Methods in cell biology (2024), pp. 151-169
Closed Access
Developing CAR T-Cell Therapies for Pediatric Solid Tumors
Gabriele Canciani, Francesco Fabozzi, Claudia Pinacchio, et al.
Pediatric Drugs (2024)
Closed Access
The role of neutrophils in osteosarcoma: insights from laboratory to clinic
Ming Xia, Yu Han, Lihui Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Dual impact of radiation therapy on tumor-targeting immune responses
Céline Mirjolet, Jérémy Baude, Lorenzo Galluzzi
International review of cell and molecular biology (2023), pp. xiii-xxiv
Closed Access | Times Cited: 1
Innate immune effectors in cancer
Lorenzo Moretta, Paola Vacca
Seminars in Immunology (2023) Vol. 67, pp. 101760-101760
Open Access
Page 1

Scroll to top